How insurers could have gamed ACA risk adjustment

Oregon-based provider and insurer Zoom is being investigated for allegations it tampered with medical claims to make sure it didn’t have to pay into the risk adjustment pool for the Affordable Care Act (ACA) marketplaces.

Axios reports Zoom is “likely an aberration” in its alleged fraud. It's possible, however, that other insurers have taken similar strategies, as they've been known to overcharge Medicare Advantage’s risk adjustment program through overcoding, with one study estimating those practices could cost CMS $200 billion over the next decade. 

In this case, Zoom supposedly changed the codes on claims for patients who were going to its own clinics and had Zoom as their insurer. For example, a patient with hypertension could have been upcoded to a more serious condition like congestive heart failure.

Read the full article at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.